secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001437749-22-026051
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris Pharmaceuticals increases ATM offering capacity to $75M under amended Jefferies agreement
--------------------------------------------------------------------------------

- As of Nov 4, 2022, Pieris had sold $33.6M of stock under the prior $50M ATM program.
- Amendment raises aggregate offering amount to $75M, exclusive of shares previously sold.
- Jefferies will use commercially reasonable efforts for at-the-market sales on Nasdaq.
- Company is not obligated to sell any shares; other terms of the Sales Agreement unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774922026051/0001437749-22-026051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774922026051/pirs20221103_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-026051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer